Categories
Drug Eluted Stent
Are the Reported Advantages of Pacitaxil Therapy worth the potential risks?
Darren Schneider, MD | 2020 Annual Meeting
Paclitaxel: Friend or Foe…Data Driven Decision Making (Sponsored by Boston Scientific)
Michael Jaff, DO | 2020 Annual Meeting
A Real World Experience of Drug Eluting and Non-drug Eluting Stents In Lower Extremity Peripheral Arterial Disease
Pavel Kibrik, MD | 2018 Annual Meeting
Coronary Drug-Eluting Stents for the Treatment of Threatened LowerExtremity Bypass Grafts: a Single Institution Case Series
Jon Quatromoni, MD | 2018 Annual Meeting
Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal Arteries
Abhisekh Mohapatra, MD | 2018 Annual Meeting